Skip to main content
Hit enter to search or ESC to close
Close Search
Enveric BiosciencesEnveric BiosciencesEnveric BiosciencesEnveric BiosciencesEnveric Biosciences
Menu
  • Company
  • Team
  • Psybrary™
  • Pipeline
  • Investors
    • Investor Overview
    • Press Releases
    • Media Coverage
    • Events + Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • News Alerts
  • Contact
  • twitter facebook linkedin
    Media Coverage

    Enveric Biosciences Files Provisional Patent for Cannabinoid + Celecoxib Conjugate EV104 after Successful Synthesis [IPO Edge]

    By EnvericFebruary 8, 2022No Comments

    https://finance.yahoo.com/news/enveric-biosciences-files-provisional-patent-214536823.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZW52ZXJpYy5jb20v&guce_referrer_sig=AQAAAIp7hCuGPXC1J-RCbbPJx9NsQx6Vv_FJkaRKGgsvfN6gOH4gXdA-Asvck2OuCViP4Xuk_XgLTMWBu2e4cKprhWS4Yo9pSGsXuXEBVV9JhnthUovjabluWHepMDqRGj14_EPIjnoXICNk8rB_uf_w13TzI_r9DobeVVdjBEjOFbD6

    Leave a Reply

    You must be logged in to post a comment.

    Company

    Team

    Psybrary™

    Pipeline

    Investors

    Contact

    Sign Up for Updates

    © 2026 Enveric Biosciences | Terms of Use | Privacy Policy

    Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.

    Share
    Share Share Share Pin
    Close Menu
    • Company
    • Team
    • Psybrary™
    • Pipeline
    • Investors
      • Investor Overview
      • Press Releases
      • Media Coverage
      • Events + Presentations
      • Stock Information
      • SEC Filings
      • Corporate Governance
      • News Alerts
    • Contact
    • twitter
    • facebook
    • linkedin